Salarian Mehrnaz, Samimi Raziye, Xu William Z, Wang Zhiqiang, Sham Tsun-Kong, Lui Edmund M K, Charpentier Paul A
Biomedical Engineering Graduate Program, University of Western Ontario, London, Ontario N6A 5B9, Canada.
The Ontario Ginseng Innovation & Research Consortium, London, Ontario N6A 5C1, Canada.
ACS Biomater Sci Eng. 2016 Nov 14;2(11):1872-1882. doi: 10.1021/acsbiomaterials.6b00222. Epub 2016 Sep 2.
Next generation drug-loaded polymer scaffolds for hard tissue engineering require unique structures to enhance release kinetics while enabling bone cell growth (osteogenesis). This study examined the encapsulation of the pro-angiogenic mediator, ginsenoside Rg, into biodegradable poly(propylene fumarate) (PPF) microspheres to facilitate osteogenesis, while examining the release mechanism using advanced X-ray absorption near edge structure spectroscopy (XANES). Ginsenoside Rg-loaded PPF microspheres were prepared using both an emulsion method and a microfluidic device, with the microfluidic technique providing tunable unimodal PPF spheres ranging in size from 3 to 52 μm by varying the flow rates. The morphology and composition of the Rg-loaded PPF microspheres were characterized using FTIR, XRD, and XANES to examine the distribution of ginsenoside Rg throughout the polymer matrix. Encapsulation efficiency and release profiles were studied and quantified by UV-Vis spectrophotometry, showing high encapsulation efficiencies of 95.4 ± 0.8% from the microfluidic approach. Kinetic analysis showed that Rg release from the more monodisperse PPF microspheres was slower with a significantly smaller burst effect than from the polydisperse spheres, with the release following Fickian diffusion. The released Rg maintained its angiogenic effect , showing that the PPF microspheres are promising to serve as vehicles for long-term controlled drug delivery leading to therapeutic angiogenesis in bone tissue engineering strategies.
用于硬组织工程的下一代载药聚合物支架需要独特的结构来增强释放动力学,同时促进骨细胞生长(骨生成)。本研究考察了将促血管生成介质人参皂苷Rg封装到可生物降解的聚富马酸丙二醇酯(PPF)微球中以促进骨生成,同时使用先进的X射线吸收近边结构光谱(XANES)研究释放机制。采用乳液法和微流控装置制备了载人参皂苷Rg的PPF微球,通过改变流速,微流控技术可提供尺寸范围为3至52μm的可调单峰PPF球。使用傅里叶变换红外光谱(FTIR)、X射线衍射(XRD)和XANES对载Rg的PPF微球的形态和组成进行了表征,以研究人参皂苷Rg在整个聚合物基质中的分布。通过紫外可见分光光度法研究并量化了包封效率和释放曲线,微流控方法显示出95.4±0.8%的高包封效率。动力学分析表明,与多分散微球相比,从更单分散的PPF微球中释放Rg的速度较慢,突释效应明显较小,释放遵循菲克扩散。释放的Rg保持其血管生成作用,表明PPF微球有望作为长期可控药物递送的载体,在骨组织工程策略中实现治疗性血管生成。